Search results
Once-in-a-week insulin jab nears approval in India: Report
CNBC Awaaz· 4 days agoInsulin Icodec, the first weekly insulin jab from Novo Nordisk, which also makes weight-loss drug...
Can Zaynich do for Wockhardt what Ozempic did for Novo Nordisk?
The Economic Times· 1 day agoThis is akin to the opportunity which diabetes drug Ozempic provided to its innovator Novo Nordisk...
Novo Nordisk must cut prices of weight-loss drug, Biden says in USA Today piece - ET HealthWorld |...
The Economic Times· 5 days agoWeight-loss Drug Price Cut: Biden and Sanders also said Eli Lilly was charging high prices for its...
Novo, Lilly fall after Biden calls for cheaper obesity drugs
CNBC Awaaz· 4 days agoNovo Nordisk A/S and Eli Lilly & Co. shares fell Tuesday after US President Joe Biden continued his...
Wegovy maker, solar panels, and a warehouse: NC’s 5 biggest jobs announcements of 2024
Durham Herald-Sun· 6 days agoAccording to the manufacturer, Danish insulin maker Novo Nordisk, around 25,000 people in the U.S....
Wegovy, Ozempic linked with sight-threatening eye disorder in study - ET HealthWorld
The Economic Times· 3 days agoLondon: Patients using Novo Nordisk's wildly popular weigh-loss drug Wegovy and its similar...
Diabetes patients on GLP-1s instead of insulin have lower cancer risk, study shows - ET HealthWorld
The Economic Times· 1 day agoGLP-1 treatments for type 2 diabetes have been on the market for nearly 20 years. The newer...
10 clinical trials to watch in the second half of 2024
BioPharma Dive· 6 days agoStudy results are expected for two closely watched obesity drugs, while key tests await for a...
Wegovy, Ozempic Diabetes Drugs Linked To Serious Eye Conditions: New Study
Times Now· 10 hours agoJAMA Ophthalmology Study Highlights RisksA recent study published in JAMA Ophthalmology has...
Weekly-once insulin jab may soon come to India
The Economic Times· 4 days agoIn what could be a respite for people who need insulin jabs every day, a new weekly insulin dosage by Danish drug maker Novo Nordisk has got closer to...